OpenEvidence
AI search engine for doctors providing evidence-based medical answers.
Product
Selected offerings — the AI products recorded here, not the vendor's full catalogue.
-
Answers clinical questions with citations to the medical literature.
Similar products 27
No sourced competitor yet: no filing, vendor document or measured-market report read so far names a rival for this company, so none is asserted. The companies below are the closest by what their products do.
Closest alternatives are pairs a vendor page itself compares. Similar products are matched from what each product does; nothing in that group is asserted as a rivalry.
Sources
- Total funding
-
OpenEvidence hits $12B valuation, with new round led by Thrive, DST, TechCrunch, January 21, 2026. Read via stockanalysis.com's citation for this figure on 2026-08-27.
- Valuation
-
Third-party database · 14 Apr 2026
Buy and Sell OpenEvidence Stock, $12.19B Valuation - Forge, Forge Global, 2026-04-16. post-money valuation of the round dated 2026-04-14. Forge Global figures are derived from the company's certificate of incorporation — the post-money valuation of the named priced round, not a secondary-market implied price.. Read via stockanalysis.com's citation for this figure on 2026-08-27.
- Employees
-
Forbes company profile for OpenEvidence, "Employees" stated as of April 2026. Read 2026-08-27.
- Founded
-
Wikipedia infobox "founded" field, read 2026-08-27.
Open OpenEvidence in the directory
Something wrong here? Send a correction — quote this company id: openevidence.